Site Catalyst Does Red Wine Really Reduce Risk Of Lung Cancer?
Skip navigation
Dr. Len's Blog
Expert perspective, insight and discussion
SHARE »

Dr. Len's Cancer Blog

The American Cancer Society

Does Red Wine Really Reduce Risk Of Lung Cancer?

by Dr. Len October 15, 2008

Do you really believe that red wine—and only red wine among the alcoholic beverages—really reduces the risk of lung cancer?

 

Last week’s research report that smokers who drink red wine had a substantially decreased risk of developing lung cancer drew such a conclusion.  And the media climbed right on the bandwagon.

 

But I am not so certain that we can reasonably make that connection, and would suggest that until the data is replicated with an even larger study we should be cautious in suggesting that smokers should suddenly switch their adult beverage of choice to red wine from what I suspect is the more typical beer, bourbon and scotch.

 

The study as reported in the current issue of Cancer Epidemiology, Biomarkers and Prevention did say that their data showed “moderate red wine consumption” was related to a lower level risk for lung cancer.  Drink more red wine and you had a much lower incidence of lung cancer if you ever smoked cigarettes.  The same effects were not seen with other alcoholic beverages, including white wine.

 

I am not faulting the researchers for the work they did.  In fact, it was a large study of over 84,000 men in California and the methods they used were very appropriate. The study was well done.

 

But when I was asked to take a look at the article by a reporter for a national news service, I did note some statistics that gave me a moment’s pause.  That, combined with my past experience with reports on the health benefits of red wine, suggests to me that we can’t be too quick to say that red wine is good for you if you smoke.

 

My comments, as correctly quoted in the news report, were essentially that this was interesting research but that it needed to be confirmed.  In addition, I also noted that increased wine consumption can be associated with an increased risk of other cancers, including breast cancer and head and neck cancer.

 

When I reviewed the article in the medical journal, I noted that there in fact was a significant reduction in lung cancer for red wine drinkers who were “ever smokers.”  Those reductions, by the statistics, were impressive, up to a decrease of 61% if you drank one or more glasses of red wine a day. 

 

But then I also noted that when the statistics were more carefully examined, the range of possible percentages of the effect of red wine ran from a reduction of as much as 84% to an increase of as much as 78%.

 

Without getting too complicated on the statistics, the reality was that for each level of red wine consumption, there was a wide range of possible answers (what we call the “confidence interval”) that might have shown up on different analyses of the data in other studies or at different times.  The level of certainty was not great that these marked reductions were in fact the “right” answer.

 

The reason for this is that—despite looking at tens of thousands of men—you would still have to look at thousands more before getting the level of statistical definition that would narrow these confidence intervals and make the statistics more reliable.

 

When the researchers did an additional analysis, where they looked at the “trend” of the data, the numbers in combination led to the conclusions that they reported in their article, namely that the trend of the data suggested that there was indeed a relationship.

 

It is important to keep in mind that this type of research is complicated, and so are the statistical analyses.  I even asked my statistics colleagues at work to take a look at the numbers, and they essentially came to the same conclusion. 

 

The other question is that although the researchers looked a number of related factors and tried to eliminate them as the cause for the “red wine effect,” I am still concerned that there could have been some other unidentified factor they may not have measured.

 

This may sound corny, but I just don’t know a lot of smokers who choose red wine as their “alcohol of choice”.  Those that do could have other lifestyle habits that separate them from their beer/bourbon/scotch drinking buddies that could theoretically explain the observation in the study.

 

I have been through the “red wine experience” in the past.  I can’t remember the exact time frame, but as best I recall it was in the early 1990’s when there was research touting the health benefits of red wine.  Even CBS’ 60 Minutes got into the act, suggesting that red wine consumption may be beneficial, citing the experience of the French who consume larger quantities of red wine without the level of anticipated ill effects.

 

Since that time, there has been persistent interest in the health potential of red wine—or one of its ingredients—and the possibility that it may be associated with increased longevity.

 

(I have to laugh a bit at my memories of the red wine story.  While in practice as a general internist back in the early 1990’s, an elderly lady—I think she was about 82 years young—who was in reasonably good health came into my office for her regular visit clutching a paper bag.  In the bag was a slightly used bottle of red wine.  She had seen the television report on red wine, and although she had been a teetotaler before that, she went out and bought herself a bottle of wine and started drinking small amounts. 

 

When she asked me if this was good for her, I advised her that I thought she had been doing fine without the wine.  No real objection, mind you, but I wouldn’t recommend to her that she take up this new habit for her health.

 

At which point, in all seriousness, she turned to me and asked if I thought the wine store would give her money back, since I—her doctors--didn’t think she really didn’t need the wine after all.)

 

The bottom line: the research is well done, but I don’t have the confidence that I would like to have in the conclusion that red wine drinking reduces your risk of lung cancer if you are or have been a smoker.  Any claims along that line should be viewed cautiously.

 

As the authors correctly concluded in their report:

 

“We observed an inverse association between red wine intake and risk of lung cancer among ever-smokers, which suggests further research into the lung cancer chemopreventive agents that occur in abundance in red wine.  These findings, however, should be confirmed in future epidemiologic studies that separately examine the effect of red wine from other alcoholic beverages.”

 

To which I say, “Cheers!”

 

 

 

 

 

Filed Under:

Lung Cancer | Prevention | Tobacco

Comments

10/28/2008 3:59:22 PM #

Gregory D. Pawelski

Polyphenols found in red wine - such as resveratrol - are thought to have anti-oxidant or anti-cancer properties. Polyphenols are antioxidant compounds found in the skin and seeds of grapes. When wine is made from these grapes, the alcohol produced by the fermentation process dissolves the polyphenols contained in the skin and seeds. Red wine contains more polyphenols than white wine because the making of white wine requires the removal of the skins after the grapes are crushed.

----------

What is interesting in cancer is the anti-angiogenic enhancer and potentiator effect of the alcohol in red wine. Alcohol seems to reduce the angiogenic secretions by the tumor cells. If it does that, it could both reduce these secretions and make an anti-angiogenesis drug less resistant to the tumor cells, making it more effective. In the presence of an anti-angiogenesis drug, you can have a lethel 1-2 combination which knocks out the new blood vessels which are dependent for survival of the cancer.

----------

Resveratrol is a type of polyphenol called a phytoalexin, a class of compounds produced as part of a plant’s defense system against disease. It is produced in the plant in response to an invading fungus, stress, injury, infection or ultraviolet irradiation. Red wine contains high levels of resveratrol, as do grapes, raspberries, peanuts and other plants.

----------

Resveratrol has been shown to reduce tumor incidence in animals by affecting one or more stages of cancer development. It has been shown to inhibit growth of many types of cancer cells in cell culture. Evidence also exists that it can reduce inflammation. It also reduces activation of NF kappa B, a protein produced by the body’s immune system when it is under attack. This protein affects cancer cell growth and metastasis. Resveratrol is also an antioxidant.

----------

Many of the new gene-targeted drugs do not target enough genes. Cancer researchers now recognize hundreds if not thousands of genes must be down-regulated to conquer cancer. In one study, for example, at least 74 genes must be controlled in renal cancer alone (Cancer Biol Ther. 2004 Sep;3(9):889-90. Epub 2004 Sep 24). So-called promiscuous gene inhibitors must be found. A targeted drug like Sutent only down-regulates a small number of genes.

----------

Resveratrol favorably switches many genes, and this has been shown in a renal cancer cell line (PMID: 15467424)(BMC Urol. 2004 Jun 22;4:9). It appears that resveratrol can target “all” genes involved in cancer. It is possible that it also chemosensitizes tumor cells, all the genes within the cell (a potentiator of chemotherapy drugs).

----------

An article appeared in the September issue of Journal of Internal Medicine, “Cell culture detection of microvascular cell death in clinical specimens of human neoplasms and peripheral blood,” reporting a novel system that was developed for testing anti-microvascular drug effects in fresh biopsy specimens of human tissue, cavitary fluids and blood.

----------

Three-dimensional microclusters of tumor cells were isolated from fresh tumor biopsy specimens and cultured for 96 hours (polypropylene, round-bottomed, 96-well microplates) in the presence and absence of test drugs.

----------

A private laboratory has worked with the use of alcohol as an anti-angiogenic enhancer and potentiator and has measured it with fresh “live” tumor specimens in cell culture assays.

----------

What alcohol does is to reduce the secretion of VEGF by the tumor cells. The assay shows the abrogating effect of alcohol upon VEGF. It both reduces VEGF and makes a drug like Avastin work better, possibly overcoming tumor resistance to Avastin.

----------

Wound healing requires neovascularization. Alcoholics have notoriously poor wound healing. In rat systems, relatively low doses of alcohol do impair vascularization in wounds.

----------

Alcolol may have a membrane effect, basically puts t

Gregory D. Pawelski

10/28/2008 4:02:12 PM #

Gregory D. Pawelski

the cell to sleep so that it doesn’t think it requires a blood supply. In the presence of a drug like Avastin, you have a lethel 1-2 combination which knocks out the new vessels which are dependent on VEGF for survival.

----------

For an antiangiogenesis effect, it would be necessary to drink a bottle of wine per day, an amount considered unhealthy. A better option may be polyphenols extracted from plants converted into a tablet. The use of plant polyphenols as therapeutic tools presents important advantages, because they have a good safety profile, a low cost and they can be obtained everywhere on the planet.

----------

Source: J Intern Med 2008; 264: 275-287

Gregory D. Pawelski

4/8/2009 1:49:36 AM #

Dan

It's a shame you don't insist on the same rigorous research methods when it comes to the alleged dangers of exposure to secondhand smoke. In my non-scientific world, that makes you a hypocrite.

Dan

4/12/2009 5:44:32 PM #

Pilar Garcia Garibay

365847
Hello, I'm from Mexico City and I've been in surgery last week. It was mastectomy because it was found malignacy in 2 tumors and all the gangles. I'm going through quimiotherapy and radiotherapy. I saw a Dr.who works to increases the inmunology sistem with natural products. I'm looking in the web for information about the efects he said this product does.
1. Inhibited angiogenic factor.
2."Citocinas stabilizator (it works to get a better inmunologic answer.
3. Antioxidant activity.
4. It modified the "acidos grasos".
If you can help me with information about the product called Leprec.
Thanks so much.
Pilar

Pilar Garcia Garibay

Add comment


(Will show your Gravatar icon)

biuquote
  • Comment
  • Preview
Loading



About Dr. Len

Dr. Len

J. Leonard Lichtenfeld, MD, MACP - Dr. Lichtenfeld is Deputy Chief Medical Officer for the national office of the American Cancer Society.

MORE »

 

Recent Comments

Comment RSS
GIVE BACK »